Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulm...
Q2 2026
Aug 12, 2026
Q1 2026
May 7, 2026
FY 2025
Mar 23, 2026
Q4 2025
Q3 2025
Nov 12, 2025